# Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations

> **NCT07354269** · PHASE4 · RECRUITING · sponsor: **Sinovac Biotech Co., Ltd** · enrollment: 180 (estimated)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** sIPV
- **BIOLOGICAL:** DTaP-IPV-Hib

## Key facts

- **NCT ID:** NCT07354269
- **Lead sponsor:** Sinovac Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-26
- **Primary completion:** 2026-04-11
- **Final completion:** 2026-05-02
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07354269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07354269, "Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT07354269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*